Clinical trial
Bumetanide Versus Furosemide in Heart Failure
NCT00372762 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Withdrawn
Key facts
| NCT number | NCT00372762 |
|---|---|
| Title | Bumetanide Versus Furosemide in Heart Failure |
| Official title | Bumetanide Has a More Favourable Effect on Insulin Resistance Than Furosemide in Patients With Heart Failure - A Pilot Study |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Collaborators | University of Western Ontario, Canada |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Furosemide, Bumetanide, furosemide, bumetanide |
| Enrollment | 0 |
| Start date | Jan 1, 2011 |
| Primary completion | Jan 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Sep 7, 2006 |
| Last update posted | Mar 27, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: